Life events and schizophrenia: the "triggering" hypothesis

The present paper reviews the life event research specific to schizophrenia with the goal of assessing the extent to which recent empirical studies have implicated life stress variables as precipitants of acute episode of the disorder (i.e. the "triggering" hypothesis). Different methodological strategies used in life event research are reviewed along with the substantive findings from quasi-experimental and controlled studies of schizophrenic patients. It is concluded that stressful life events have been found to be part of the pool of factors associated with the onset of acute schizophrenic episodes, but evidence is still lacking to indicate that this association is necessary or direct one. Recommendations are made regarding the types of future studies required to fill the gaps in the existing literature.

Single-dose evaluation of a new enteric-coated aspirin preparation

The bioavailability of a new enteric-coated tablet of aspirin (Ecotrin, Smith, Kline and French) was evaluated after single doses to eight volunteers. One tablet was administered to each subject on four occasions--twice after a light breakfast, once after a heavy breakfast and once after pretreatment with metoclopramide. The study utilized non-invasive techniques. The rate of absorption of aspirin was estimated by the time course of concentrations of salicylate in saliva, while the total bioavailability was determined by the recovery of total salicylate in urine. The urinary recovery of aspirin from all 32 trials was 575 +/- 25 mg (mean +/- standard error), representing 89% +/- 4% of the administered dose. The different treatments did not significantly alter the urinary recovery. The absorption of aspirin from the enteric-coated tablets was delayed and slow. Absorption was retarded by a heavy meal and hastened by pretreatment with metoclopramide. The effect of metoclopramide is consistent with the release of aspirin in the small intestine. Overall, the single-dose tests indicated satisfactory functioning of the enteric coating.

The use of human adenovirus 2 in the study of the xeroderma DNA-repair defect

Ultraviolet-irradiated adenovirus 2 assayed by counting plaques on monolayers of human fibroblast strains is up to 30-fold more sensitive than normal if the strains used as viral hosts are prepared from persons having xeroderma pigmentosum. This plaque assay has been used as an extremely discriminating technique in the study of the xeroderma repair defect. With this assay, every xeroderma fibroblast strain tested has been found to exhibit a DNA-repair defect, including those previously judged by other methods to have normal DNA repair.